BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24870301)

  • 1. [Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma].
    Rim MY; Kwon OS; Ha M; Kim JS; Ko KI; Kim DK; Jang PK; Han JY; Park PH; Jung YK; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2014 May; 63(5):292-8. PubMed ID: 24870301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
    Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
    BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
    Kwon OS; Kim JH; Kim JH
    Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK
    Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].
    Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK
    Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.
    David D; Raghavendran A; Goel A; Bharath Kumar C; Kodiatte TA; Burad D; Abraham P; Ramakrishna B; Joseph P; Ramachandran J; Eapen CE
    Indian J Gastroenterol; 2017 Sep; 36(5):373-379. PubMed ID: 28975595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
    Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
    J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.
    Benhammou JN; Aby ES; Shirvanian G; Manansala K; Hussain SK; Tong MJ
    Sci Rep; 2020 Jun; 10(1):9902. PubMed ID: 32555268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
    Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Yoon CH; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1090-1096. PubMed ID: 29847489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee YB; Ha Y; Chon YE; Kim MN; Lee JH; Park H; Kim KI; Kim SH; Rim KS; Hwang SG
    Clin Mol Hepatol; 2019 Mar; 25(1):52-64. PubMed ID: 30360031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes in patients with hepatocellular carcinoma associated with metabolic syndrome.
    Yoshida N; Takayama T; Midorikawa Y; Higaki T; Nakayama H; Moriguchi M; Tsuji S
    World J Surg; 2015 Feb; 39(2):471-7. PubMed ID: 25331727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
    Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.